click to show more information

click to hide/show information About your Search

20130101
20130131
Search Results 0 to 0 of about 1
has an advantage when it comes to type ii diabetes. they are further along and in the best position of any farm sewell suit call company to release a serious drug application which is a type two diabetes inhibitor. see a very bright future ahead for j&j. like them both but like j&j better. >> ennis, what do you think? >> i agree with steve. health care as a whole is one of the best stocks to be in but i disagree with j&j over pfizer and if you look at the charts you'll see what i mean. j&j has had a nice uptrend and it has had trouble breaking out above the october high so the october high was around 72, 75ish. it hasn't been able to get up there convincing which whereas if we look at pfizer in contrast you'll see that pfizer has been able to convincingly break out about the october highs showing more strength from the buyers and that's why i like it technically. >> i do think that's an important point. also, let's remember. even though pfizer has done better and most phrma has done better. j&j did print a three-year high so a post-crisis high so it's doing very well itself. the rea
Search Results 0 to 0 of about 1